Praneeth Sudalagunta

10PUBLICATIONS
106CO-AUTHORS
Inter-organisational, extra-organisational and global information systemsCancer diagnosisMedical mycologyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 12, 2026
The Oncology Research Information Exchange Network (ORIEN) - Building a Real-World Collaborative, Patient-driven Infrastructure for Discovery Research and Precision Oncology.

|Jun 03, 2026
Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma.

|Oct 08, 2025
Genomics Define Malignant Transformation in Myeloma Precursor Conditions.

Francesco Maura, P Leif Bergsagel, Bachisio Ziccheddu

|Sep 22, 2025
Target antigen and plasma cell phenotype are critical factors for sensitivity to response-adapted daratumumab therapy.

Mark B Meads, Xiaohong Zhao, David Noyes

|Jul 15, 2025
Genome-level selection in tumors as a universal marker of resistance to therapy.

Erez Persi, Praneeth R Sudalagunta, Yuri I Wolf

|May 05, 2025
Epigenetic Plasticity Drives Carcinogenesis and Multi-Therapy Resistance in Multiple Myeloma.

Rafael Renatino Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads

Pageof 2

Frequent Collaborators

10 joint publications

Rafael Renatino Canevarolo

6 joint publications

Ariosto Siqueira Silva

5 joint publications

Kenneth H Shain

4 joint publications

Rachid C Baz